Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study.
Zhang N, Liu L, Dumitru CD, Cummings NR, Cukan M, Jiang Y, Li Y, Li F, Mitchell T, Mallem MR, Ou Y, Patel RN, Vo K, Wang H, Burnina I, Choi BK, Huber HE, Stadheim TA, Zha D.
Zhang N, et al. Among authors: dumitru cd.
MAbs. 2011 May-Jun;3(3):289-98. doi: 10.4161/mabs.3.3.15532. Epub 2011 May 1.
MAbs. 2011.
PMID: 21487242
Free PMC article.